← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RICONPHARMA LLC · Approved 2024-11-22

Drug application

FDA Application #

ANDA215796

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

OXCARBAZEPINE

Active ingredients

OXCARBAZEPINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

RICONPHARMA LLC

Manufacturer

Ingenus Pharmaceuticals, LLC

First approval

2024-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown